NON-GAAP AND FORWARD-LOOKING STATEMENTS Non-GAAP Measures and Reconciliations to GAAP Measures Adjusted EBITDA, Adjusted EBITDA margin, Adjusted income from continuing operations, Adjusted diluted earnings per share from continuing operations ("Adjusted EPS"), and free cash flow are non-GAAP financial measures. JBT Marel provides non-GAAP financial measures in order to increase transparency in our operating results and trends. These non-GAAP measures eliminate certain costs or benefits from, or change the c ...

Exhibit 99.1 News Release JBT Marel Corporation 333 W. Wacker Drive Suite 3400 Chicago, IL 60606 JBT Marel Corporation Reports Fourth Quarter and Full Year 2025 Results and Establishes 2026 Guidance with Continued Growth Fourth Quarter 2025 Highlights: (Results are from continuing operations) Full Year 2025 Highlights: (Results are from continuing operations) CHICAGO, February 23, 2026 - JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segme ...

CHICAGO--(BUSINESS WIRE)--JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segments of the food & beverage industry, today reported financial results for the fourth quarter and full year 2025. "We delivered on our ambitious expectations for our first year operating as JBT Marel and demonstrated that we are truly better together," said Brian Deck, Chief Executive Officer. "Our team's strong execution, successful integration e. ...

CHICAGO--(BUSINESS WIRE)--JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segments of the food & beverage industry, announced today that its previously disclosed plan to realign its reportable segments went into effect for the fourth quarter of 2025. The change is driven by the integration of the Company's operating model following the combination of legacy JBT and legacy Marel organizations. As a result of the segment real. ...

Company Overview - JBT Marel Corporation is a leading provider of integrated automation and processing solutions for the food, beverage, and health industries globally, leveraging advanced technology for efficiency and product quality [6][9] - As of February 12, 2026, the company's stock price was $163.36, with a market capitalization of $8.58 billion and a revenue of $3.26 billion for the trailing twelve months (TTM) [4][8] Recent Transaction - On February 13, 2026, ACK Asset Management LLC disclosed the full liquidation of its position in JBT Marel Corporation, selling 350,546 shares for an estimated value of $49.23 million [2][5] Financial Performance - JBT Marel reported better-than-expected third-quarter revenue of $1 billion, with 49% coming from recurring revenue, and an adjusted EBITDA of $171 million, reflecting a 17.1% margin [7] - The company raised its full-year 2025 revenue guidance to a range of $3.76 billion to $3.79 billion, indicating solid operational execution [7] Market Position - JBT Marel's shares have increased by 30.3% over the past year, outperforming the S&P 500 by 17.44 percentage points [8] - The company serves a diversified customer base across various sectors, including food, beverage, pharmaceutical, pet food, and industrial, with a global presence [9] Debt and Profitability - The company has a net debt of approximately $1.79 billion, with a net debt to pro forma adjusted EBITDA ratio of 3.1x, indicating meaningful leverage [10] - Integration costs, restructuring expenses, and acquisition-related amortization continue to impact GAAP profitability [10] Long-term Considerations - For long-term investors, the critical question revolves around whether synergy targets and margin expansion can outpace integration risks, as successful execution could lead to durable earnings power [11]

Core Viewpoint - JBT Marel Corporation will host an Investor Day on March 26, 2026, to discuss strategic priorities, growth initiatives, and financial objectives [1][2]. Company Overview - JBT Marel Corporation is a leading global technology solutions provider in the food and beverage industry, formed by the integration of JBT and Marel legacy organizations [3]. - The company focuses on transforming the future of food by offering unique and integrated solutions, including technology, systems, and software for various food and beverage markets [3]. - JBT Marel aims to optimize food yield and efficiency, improve food safety and quality, enhance uptime and proactive maintenance, and reduce waste and resource use across the global food supply chain [3]. - The company operates in over 30 countries, providing sales, service, manufacturing, and sourcing operations [3].

Company Overview - JBT Marel (JBTM) is a member of the Business Services group, which consists of 259 companies and currently ranks 5 in the Zacks Sector Rank [2] - JBT Marel has a Zacks Rank of 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] Performance Analysis - JBT Marel has gained approximately 9.4% year-to-date, outperforming the Business Services sector, which has returned an average of -12.3% [4] - In comparison, Mirion Technologies, Inc. (MIR) has seen a significant increase of 42.9% year-to-date, also holding a Zacks Rank of 2 (Buy) [4][5] Industry Context - JBT Marel is part of the Technology Services industry, which includes 124 companies and currently ranks 69 in the Zacks Industry Rank [6] - The Technology Services industry has an average gain of 11.5% year-to-date, indicating that JBT Marel is slightly underperforming its industry [6] Analyst Sentiment - The Zacks Consensus Estimate for JBT Marel's full-year earnings has increased by 7.8% over the past quarter, reflecting improved analyst sentiment and a stronger earnings outlook [3]

Financial Performance - Total revenue for Q3 2025 reached $1,001.3 million, a 120.6% increase compared to $453.8 million in Q3 2024, driven by the acquisition of Marel which contributed $536.5 million[154] - Gross profit for the quarter was $359.8 million, with a gross profit margin of 35.9%, consistent with the same period last year[157] - Operating income for Q3 2025 was $102.1 million, reflecting a 118.2% increase from $46.8 million in Q3 2024[154] - Net income for the quarter was $66.0 million, a 69.7% increase compared to $38.9 million in the same quarter last year[154] - Adjusted EBITDA for Q3 2025 was $170.9 million, compared to $81.7 million in Q3 2024, representing an increase of 109.2%[165] - Total revenue for the nine months ended September 30, 2025, increased by $1,541.8 million or 123.5% compared to the same period in 2024[170] - JBT revenue for the nine months ended September 30, 2025, was $1,328.2 million, a 6.4% increase from $1,248.4 million in 2024[168] - Marel revenue contributed $1,462.0 million in the nine months ended September 30, 2025, with a favorable foreign currency translation impact of approximately $19.3 million[170] - Adjusted EBITDA from continuing operations for Q3 2025 was $170.9 million, significantly up from $81.7 million in Q3 2024, and for the nine months ended September 30, 2025, it reached $439.3 million compared to $202.8 million in 2024[189] Expenses and Costs - Selling, general and administrative expenses increased by $110.4 million to $222.0 million, primarily due to the Marel acquisition, but as a percentage of revenue, it decreased to 22.2% from 24.6%[158] - Research and development expenses rose by $23.3 million to $28.7 million, largely due to costs associated with the Marel business[159] - Selling, general and administrative expenses increased by $428.4 million, with expenses as a percentage of revenue rising to 27.0% from 26.1% year-over-year[172] - Research and development expenses increased by $75.6 million, primarily due to costs associated with the Marel acquisition[173] - Interest expense increased by $87.8 million due to a higher average debt balance and interest rates related to the Marel acquisition[178] Income and Loss - Income from continuing operations for Q3 2025 was $66.8 million, up from $38.1 million in Q3 2024, an increase of 75.3%[164] - Loss from continuing operations for the nine months ended September 30, 2025, was $102.8 million, compared to income of $91.5 million in 2024, a decrease of $194.3 million[181] - Income from continuing operations for Q3 2025 was $66.8 million, compared to $38.1 million in Q3 2024, while the nine-month loss from continuing operations was $(102.8) million, down from $91.5 million in the same period last year[189] Cash Flow and Liquidity - Free cash flow for the nine months ended September 30, 2025, was $163.0 million, an increase of $83.8 million compared to $79.2 million in the same period of 2024[195] - Total operating cash flows from continuing operations for the nine months ended September 30, 2025, were $224.3 million, with expectations of generating positive cash flows for the full year[203] - Cash provided by continuing operating activities for the nine months ended September 30, 2025 was $224.3 million, a $120.4 million increase from $103.9 million in 2024[208] - Cash required by continuing investing activities surged to $1,811.3 million in 2025, compared to only $31.8 million in 2024, primarily due to the acquisition of Marel[209] - Cash provided by financing activities was $490.9 million in 2025, a significant increase from cash required of $23.1 million in 2024, driven by net proceeds from Term Loan B and convertible notes[210] - As of September 30, 2025, the company had $114.9 million in cash and cash equivalents, with $102.8 million held by foreign subsidiaries[206] - Liquidity as of September 30, 2025, was $1.9 billion, including cash and borrowing ability under existing revolving credit facilities[203] - As of September 30, 2025, the company had $62.7 million drawn on its revolving credit facility with $1.7 billion available[211] - The company was in compliance with all covenants in its Second A&R Credit Agreement as of September 30, 2025[212] Restructuring and Integration - The total cost of the 2022/2023 restructuring plan was $17.5 million, completed by March 31, 2024, while the JBT Marel 2025 Integration restructuring plan is estimated to cost between $30.0 million and $35.0 million[196][197] - Cumulative cost savings from the JBT Marel 2025 Integration restructuring plan are expected to be between $50.0 million and $60.0 million, with approximately $10.0 million expected to be realized during the remainder of 2025[198] - The company closed the Marel Transaction on January 2, 2025, acquiring approximately 97.5% of Marel's equity for $983.7 million in cash consideration[202] Market and Orders - Orders remained strong, particularly in the poultry, pharmaceutical, and pet food markets, indicating healthy demand[151] - The Marel Transaction, completed on January 2, 2025, aims to create a leading global food and beverage technology solutions provider[150] Tax and Regulatory - The effective tax rate for income from continuing operations was 20.4% for Q3 2025, slightly up from 20.0% in Q3 2024[163] - The company anticipates that 2025 performance will be affected by evolving tariff costs and is taking proactive measures to mitigate these impacts[152] Debt and Hedging - Approximately 50% of the total gross outstanding debt of $1,937.0 million was variable rate debt as of September 30, 2025[218] - The company entered into five cross-currency swaps with a combined notional amount of $696.5 million to hedge the impact of variability in exchange rates on U.S. dollar denominated debt[219] - A hypothetical 10% adverse movement in currency exchange rates underlying the cross-currency swaps would have resulted in a loss in value of $65.9 million[225] - The company entered into a series of cross-currency swaps with an aggregate notional amount of $2.1 billion to hedge currency exchange components of net investments in foreign subsidiaries[226]

Financial Data and Key Metrics Changes - For Q3 2025, total revenue was approximately $1 billion, a 7% sequential increase, exceeding expectations by about $65 million [6][12] - Adjusted EBITDA margin for Q3 was 17.1%, exceeding expectations by approximately 140 basis points [6][12] - GAAP EPS for Q3 was $1.28, while adjusted EPS was $1.94, excluding certain one-time items [8][12] - The company raised its full-year 2025 revenue guidance to between $3.76 billion and $3.79 billion, reflecting strong Q3 results [12][13] Business Line Data and Key Metrics Changes - JBT segment revenue was $465 million, a 2% increase year-over-year and sequentially, with adjusted EBITDA of $71 million, a 13% decrease [10][11] - Marel segment revenue was $537 million, a 12% sequential increase, with adjusted EBITDA of $100 million and a margin of 18.6% [11] - Year-over-year synergy savings for Q3 amounted to $14 million, contributing to improved margins [7][12] Market Data and Key Metrics Changes - Combined JBT/Marel orders totaled $946 million, a 7% increase from the prior year, with strong demand in the poultry industry [3][4] - North America showed strong demand, while Europe and Asia were softer sequentially; Latin America had a good quarter with large orders [4][12] - The company ended Q3 with a backlog of $1.3 billion, providing visibility for the remainder of the year [4][12] Company Strategy and Development Direction - The integration of JBT and Marel is on track, focusing on capturing synergy savings and enhancing customer value [4][12] - New segment reporting will be introduced in Q4, dividing operations into Protein Solutions and Prepared Food and Beverage Solutions [10][12] - The company aims to achieve annual run rate savings of $150 million within three years of the combination [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing demand in the poultry market and anticipated continued investment in related projects [3][39] - The company expects to see a ramp in tariff expenses impacting margins in Q4, but remains optimistic about overall demand [8][29] - Visibility into 2026 revenue is strong, with expectations for growth supported by a healthy backlog and order pipeline [42][43] Other Important Information - The company made significant progress on deleveraging its balance sheet, reducing the leverage ratio from four times to 3.1 times by the end of Q3 [12] - A new global production center was inaugurated in Pune, India, enhancing the company's manufacturing capabilities in the Asia-Pacific region [16][18] - Sustainability remains a core focus, with the publication of the first joint sustainability report highlighting efforts to minimize waste and improve food safety [17][18] Q&A Session Summary Question: What is driving the high EBITDA margin in the Marel segment? - Management highlighted strong volume throughput and operating leverage as key factors, along with a higher share of synergies and improved technology [25][26] Question: What are the expectations for Q4 revenue and cost impacts? - Management expects lower revenue in Q4 compared to Q3 due to a one-time boost in Q3 from backlog clearance and anticipates increased tariff expenses impacting margins [28][29] Question: How is automation trending in the business? - Automation remains a key focus, particularly in the protein sector, with significant opportunities in secondary processing areas [31] Question: Can you provide insights on cross-selling opportunities? - Management noted improvements in cross-selling opportunities, with successful integration of JBT and Marel portfolios leading to stronger pipeline development [33][36] Question: What is the outlook for the AGV business? - The AGV business is expected to see strong demand moving into Q4 and 2026, despite a weaker performance in Q3 due to tariffs and delayed orders [52] Question: How is the company managing tariff impacts on pricing? - The company has enacted price increases to mitigate tariff impacts and has maintained strong order levels, indicating effective management of customer relationships [47][53]

Financial Data and Key Metrics Changes - In Q3 2025, total revenue was approximately $1,000,000,000, representing a 7% sequential increase and exceeding expectations by about $65,000,000 [5][8] - Adjusted EBITDA margin for Q3 was 17.1%, exceeding expectations by approximately 140 basis points [9] - GAAP EPS for Q3 was $1.28, while adjusted EPS was $1.94, excluding certain one-time items [10] - The company raised its full-year 2025 revenue guidance to between $3,760,000,000 and $3,790,000, reflecting strong Q3 results [15] Business Line Data and Key Metrics Changes - JBT segment revenue was $465,000,000, increasing approximately 2% year-over-year and sequentially, with adjusted EBITDA of $71,000,000, a decrease of 13% [13] - MREL segment revenue was $537,000,000, a 12% sequential increase, with adjusted EBITDA of $100,000,000 and a margin of 18.6% [13][14] - Year-over-year synergy savings for Q3 amounted to $14,000,000 [10] Market Data and Key Metrics Changes - Combined JBT Madau orders reached $946,000,000, a 7% increase from the prior year [5] - Demand was strong in North America, while Europe and Asia showed softer performance; however, Latin America had a good quarter with large orders in pet food, poultry, and juice [6] Company Strategy and Development Direction - The company plans to introduce new segment reporting for 2025, focusing on Protein Solutions and Prepared Food and Beverage Solutions [12] - The integration of JBT and Morel is on track, with actions taken to capture synergy savings and enhance customer value [7][18] - The company aims to achieve annual run rate savings of $150,000,000 within three years of the combination [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand environment, particularly in the poultry market, with visibility extending into 2026 [49][61] - The company anticipates a growth year in 2026, supported by a strong backlog and healthy demand [59][61] - Management highlighted the importance of automation in response to labor pressures in food factories, particularly in the protein sector [37] Other Important Information - The company generated operating cash flow of $224,000,000 and free cash flow of $163,000,000 for the year, with record quarterly operating cash flow of $88,000,000 in Q3 [14] - The financial leverage ratio decreased from four times at the close of the combination to 3.1 times by the end of Q3, with expectations to drop below three times by year-end [14][15] Q&A Session Summary Question: What is driving the higher EBITDA margins in the Morrel segment? - Management attributed the higher margins to increased volume, operating leverage, and synergy savings, along with improvements in meat and fish segments [30] Question: What are the expectations for Q4 in terms of revenue and costs? - Management expects lower revenue in Q4 compared to Q3 due to a pickup in Q3 that is not expected to recur, along with anticipated increases in tariff expenses impacting margins [33][35] Question: How is automation trending in the business? - Automation remains a key focus, particularly in the protein sector, with significant opportunities in secondary processing areas [37] Question: Can you provide insights on cross-selling opportunities? - Management noted improvements in cross-selling opportunities, with a strong pipeline and successful integration of sales teams from both legacy companies [42][48] Question: What is the outlook for the AGV business? - The AGV business is expected to see strong demand moving into Q4 and 2026, despite a weaker performance in Q3 due to tariffs and delayed orders [76] Question: How is the company managing tariff impacts and pricing? - The company has enacted price increases to mitigate tariff impacts and has been fair with customers, resulting in strong order retention [78]